Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 147 entries
Sorted by: Best Match Show Resources per page
Gang membership and marijuana use among African American female adolescents in North Carolina.

Substance abuse and rehabilitation

Wechsberg WM, Doherty IA, Browne FA, Kline TL, Carry MG, Raiford JL, Herbst JH.
PMID: 26635492
Subst Abuse Rehabil. 2015 Nov 09;6:141-50. doi: 10.2147/SAR.S93304. eCollection 2015.

The southeastern US sustains the highest high school dropout rates, and gangs persist in underserved communities. African American female adolescents who drop out of school and are gang members are at substantial risk of exposure to severe violence, physical...

Substance use disorders in military veterans: prevalence and treatment challenges.

Substance abuse and rehabilitation

Teeters JB, Lancaster CL, Brown DG, Back SE.
PMID: 28919834
Subst Abuse Rehabil. 2017 Aug 30;8:69-77. doi: 10.2147/SAR.S116720. eCollection 2017.

Substance use disorders (SUDs) are a significant problem among our nation's military veterans. In the following overview, we provide information on the prevalence of SUDs among military veterans, clinical characteristics of SUDs, options for screening and evidence-based treatment, as...

Examining the relationship between ethnicity and the use of drug-related services: an ethnographic study of Nepali drug users in Hong Kong.

Substance abuse and rehabilitation

Tang WM.
PMID: 25114609
Subst Abuse Rehabil. 2014 Jun 20;5:53-62. doi: 10.2147/SAR.S61885. eCollection 2014.

A recent survey has shown that Nepali drug users in Hong Kong tend to have a low rate of usage of day-care and residential rehabilitation services, but a high rate of usage of methadone services. Little is known about...

New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.

Substance abuse and rehabilitation

Soyka M.
PMID: 25610012
Subst Abuse Rehabil. 2015 Jan 06;6:1-14. doi: 10.2147/SAR.S45585. eCollection 2015.

Opioid maintenance therapy is a well-established first-line treatment approach in opioid dependence. Buprenorphine, a partial opioid agonist, has been found by numerous studies to be an effective and safe medication in the treatment of opioid dependence. At present, buprenorphine...

Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates.

Substance abuse and rehabilitation

Boscarino JA, Hoffman SN, Han JJ.
PMID: 26316838
Subst Abuse Rehabil. 2015 Aug 19;6:83-91. doi: 10.2147/SAR.S85667. eCollection 2015.

AIMS: Previously, we estimated the prevalence and risk factors for prescription opioid-use disorder among outpatients on opioid therapy using the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 and DSM-4 criteria. However, at the time, the DSM-5 criteria were...

Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals.

Substance abuse and rehabilitation

Webster LR, Camilleri M, Finn A.
PMID: 27366109
Subst Abuse Rehabil. 2016 Jun 14;7:81-6. doi: 10.2147/SAR.S100998. eCollection 2016.

Buprenorphine and buprenorphine-naloxone fixed combinations are effective for managing patients with opioid dependence, but constipation is one of the most common side effects. Evidence indicates that the rate of constipation is lower when patients are switched from sublingual buprenorphine-naloxone...

Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.

Substance abuse and rehabilitation

Mannelli P, Peindl KS, Wu LT.
PMID: 21731898
Subst Abuse Rehabil. 2011 Jun;2011(2):113-123. doi: 10.2147/SAR.S15853.

PURPOSE: Opioid dependence (OD) is a serious and growing clinical condition with increasing social costs that requires expanding treatment beyond opioid agonist substitution. The opioid antagonist naltrexone has displayed a remarkable association of theoretical effectiveness and poor clinical utility...

Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems.

Substance abuse and rehabilitation

Ghitza UE, Sparenborg S, Tai B.
PMID: 21822398
Subst Abuse Rehabil. 2011 Jul 01;2011(2):125-131. doi: 10.2147/SAR.S23030.

A great divide currently exists between mainstream health care and specialty substance use disorders (SUD) treatment, concerning the coordination of care and sharing of medical information. Improving the coordination of SUD treatment with other disciplines of medicine will benefit...

Problematic use of prescription-type opioids prior to heroin use among young heroin injectors.

Substance abuse and rehabilitation

Pollini RA, Banta-Green CJ, Cuevas-Mota J, Metzner M, Teshale E, Garfein RS.
PMID: 23293547
Subst Abuse Rehabil. 2011 Oct;2(1):173-180. doi: 10.2147/SAR.S24800.

BACKGROUND: Misuse of prescription-type opioids and related adverse health effects are increasing, but little is known about the role of these drugs as a precursor to heroin use. We conducted an exploratory study to determine the proportion of young...

Integrating substance abuse care with community diabetes care: implications for research and clinical practice.

Substance abuse and rehabilitation

Ghitza UE, Wu LT, Tai B.
PMID: 23378792
Subst Abuse Rehabil. 2013 Jan 01;4:3-10. doi: 10.2147/SAR.S39982. Epub 2013 Jan 11.

Cigarette smoking and alcohol use are prevalent among individuals with diabetes in the US, but little is known about screening and treatment for substance use disorders in the diabetic population. This commentary discusses the scope and clinical implications of...

Against professional advice: treatment attrition among pregnant methamphetamine users.

Substance abuse and rehabilitation

Lindsay B, Albrecht J, Terplan M.
PMID: 24474856
Subst Abuse Rehabil. 2011 Oct 31;2:189-95. doi: 10.2147/SAR.S25083. eCollection 2011.

Pregnant methamphetamine users who leave substance use treatment against professional advice may be at risk of poorer health outcomes. To examine the hypothesis that methamphetamine use during pregnancy may be associated with leaving substance use treatment against professional advice,...

Selective review and commentary on emerging pharmacotherapies for opioid addiction.

Substance abuse and rehabilitation

Ling W, Mooney L, Zhao M, Nielsen S, Torrington M, Miotto K.
PMID: 24474855
Subst Abuse Rehabil. 2011 Oct 28;2:181-8. doi: 10.2147/SAR.S22782. eCollection 2011.

Pharmacotherapies for opioid addiction under active development in the US include lofexidine (primarily for managing withdrawal symptoms) and Probuphine®, a distinctive mode of delivering buprenorphine for six months, thus relieving patients, clinicians, and regulatory personnel from most concerns about...

Showing 1 to 12 of 147 entries